The Board of Directors of the company has appointed Monica Shaw as Chief Executive Officer, CEO, of Oncopeptides. Shaw replaces Jakob Lindberg, who has been the CEO since November 15, 2021. Lindberg assumes his previous position as Chief Scientific Officer. A transformational year The leadershiAlready a subscriber Login You have…